Glucotrack Inc Quick Ratio (GCTK) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Glucotrack Inc   (NASDAQ: GCTK)

Glucotrack Inc 's Quick Ratio

GCTK's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 0.38 below Glucotrack Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 153 other companies have achieved higher Quick Ratio than Glucotrack Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1775 to 2686.

Explain Quick Ratio?
How much Cash & cash equivalents GCTK´s has?
What are GCTK´s Current Liabilities?




GCTK Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change -3.14 % 155.13 % 274.35 % 14.88 % -15.71 %
Y / Y Cash & cash equivalent Change -88.24 % -56.82 % 31.44 % 2174.28 % 5909.43 %
Quick Ratio MRQ 0.38 0.79 1.55 1.49 3.1
GCTK's Total Ranking # 2686 # 1775 # 1338 # 1240 # 690
Seq. Current Liabilities Change -39.94 % 4.23 % -9.89 % 71.7 % 58.21 %
Seq. Cash & cash equivalent Change -71.39 % -46.78 % -6.18 % -17.65 % 5 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 154
Healthcare Sector # 755
Overall Market # 2686


Quick Ratio Statistics
High Average Low
10.55 3.36 0
(Mar 31 2013)   (Jun 30 2018)




Financial Statements
Glucotrack Inc 's Current Liabilities $ 3 Millions Visit GCTK's Balance sheet
Glucotrack Inc 's Cash & cash equivalent $ 1 Millions Visit GCTK's Balance sheet
Source of GCTK's Sales Visit GCTK's Sales by Geography


Cumulative Glucotrack Inc 's Quick Ratio

GCTK's Quick Ratio for the trailling 12 Months

GCTK Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 65.12 % 57.71 % 36.97 % 3.04 % 34.69 %
Y / Y Cash & cash equivalent TTM Growth -17.52 % 88.78 % 345.03 % 394.93 % 88.85 %
Quick Ratio TTM 1.13 1.58 2.24 2.77 2.25
Total Ranking TTM # 3975 # 3904 # 2908 # 2395 # 3028
Seq. Current Liabilities TTM Growth -0.54 % 20.03 % 30.14 % 6.28 % -5 %
Seq. Cash & cash equivalent TTM Growth -29.34 % -15.25 % 5.49 % 30.56 % 61.73 %


On the trailing twelve months basis In spite of the year on year decrease in GCTK's Current Liabilities to $2.99 millions, cumulative Quick Ratio to 1.13 below the GCTK average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 199 other companies have achieved higher Quick Ratio than Glucotrack Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3904 to 3975.

Explain Quick Ratio?
How much Cash & cash equivalents GCTK´s has?
What are GCTK´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 200
Healthcare Sector # 893
Within the Market # 3975


trailing twelve months Quick Ratio Statistics
High Average Low
7.34 2.34 0.06
(Sep 30 2021)   (Jun 30 2018)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Adagio Medical Holdings inc   1.02 $ 7.740  Millions$ 7.562  Millions
Plus Therapeutics Inc   1.00 $ 8.587  Millions$ 8.567  Millions
Pavmed Inc   1.00 $ 4.070  Millions$ 4.088  Millions
Sonoma Pharmaceuticals Inc   0.98 $ 5.338  Millions$ 5.447  Millions
Nuwellis Inc   0.98 $ 3.922  Millions$ 4.008  Millions
Electrocore Inc   0.97 $ 11.543  Millions$ 11.933  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.96 $ 10.924  Millions$ 11.366  Millions
Medline Inc   0.96 $ 2,677.000  Millions$ 2,803.000  Millions
Neuronetics Inc   0.88 $ 24.947  Millions$ 28.309  Millions
Orthopediatrics Corp  0.87 $ 45.879  Millions$ 52.852  Millions
Haemonetics Corporation  0.85 $ 223.384  Millions$ 263.235  Millions
Lifeward ltd   0.85 $ 9.448  Millions$ 11.159  Millions
Qhslab Inc   0.84 $ 0.317  Millions$ 0.376  Millions
Intelligent Bio Solutions Inc   0.84 $ 4.141  Millions$ 4.935  Millions
Integra Lifesciences Holdings Corp  0.83 $ 274.084  Millions$ 330.881  Millions
Lifestance Health Group Inc   0.82 $ 225.943  Millions$ 274.753  Millions
Pro dex Inc   0.81 $ 10.542  Millions$ 13.086  Millions
Carlisle Companies Incorporated  0.75 $ 665.300  Millions$ 888.400  Millions
Northview Acquisition Corp  0.73 $ 12.200  Millions$ 16.622  Millions
Livanova Plc  0.73 $ 516.619  Millions$ 707.004  Millions
Angiodynamics Inc   0.72 $ 53.864  Millions$ 74.717  Millions
Rosecliff Acquisition Corp I  0.70 $ 14.000  Millions$ 19.869  Millions
Innovage Holding Corp   0.69 $ 141.326  Millions$ 203.891  Millions
Msa Safety Inc  0.69 $ 200.057  Millions$ 288.899  Millions
Valion Bio Inc   0.69 $ 2.108  Millions$ 3.046  Millions
Lensar Inc   0.69 $ 13.565  Millions$ 19.640  Millions
West Pharmaceutical Services Inc   0.68 $ 435.800  Millions$ 640.500  Millions
Nexalin Technology Inc   0.68 $ 1.005  Millions$ 1.485  Millions
Orthofix Medical Inc   0.66 $ 103.810  Millions$ 157.010  Millions
Privia Health Group Inc   0.65 $ 412.200  Millions$ 634.444  Millions

Date modified: 2026-08-31T23:26:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.